BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25562196)

  • 21. A multiplex immunoassay for the non-invasive detection of bladder cancer.
    Shimizu Y; Furuya H; Bryant Greenwood P; Chan O; Dai Y; Thornquist MD; Goodison S; Rosser CJ
    J Transl Med; 2016 Jan; 14():31. PubMed ID: 26830497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for urinary bladder cancer diagnosis and classification.
    Kural S; Jain G; Agarwal S; Das P; Kumar L
    Urol Oncol; 2024 Jul; 42(7):179-190. PubMed ID: 38594151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary levels of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer.
    Nitta Y; Konishi H; Makino T; Tanaka T; Kawashima H; Iovanna JL; Nakatani T; Kiyama H
    BMC Urol; 2012 Sep; 12():24. PubMed ID: 22943287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.
    Zhou Y; Song R; Ma C; Zhou L; Liu X; Yin P; Zhang Z; Sun Y; Xu C; Lu X; Xu G
    Oncotarget; 2017 Mar; 8(13):20719-20728. PubMed ID: 28157703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers.
    Tomiyama E; Matsuzaki K; Fujita K; Shiromizu T; Narumi R; Jingushi K; Koh Y; Matsushita M; Nakano K; Hayashi Y; Wang C; Ishizuya Y; Kato T; Hatano K; Kawashima A; Ujike T; Uemura M; Takao T; Adachi J; Tomonaga T; Nonomura N
    Cancer Sci; 2021 May; 112(5):2033-2045. PubMed ID: 33721374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder.
    McNeil BK; Sorbellini M; Grubb RL; Apolo A; Cecchi F; Athauda G; Cohen B; Giubellino A; Simpson H; Agarwal PK; Coleman J; Getzenberg RH; Netto GJ; Shih J; Linehan WM; Pinto PA; Bottaro DP
    J Transl Med; 2014 Oct; 12():199. PubMed ID: 25335552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary MicroRNAs as Potential Markers for Non-Invasive Diagnosis of Bladder Cancer.
    Erdmann K; Salomo K; Klimova A; Heberling U; Lohse-Fischer A; Fuehrer R; Thomas C; Roeder I; Froehner M; Wirth MP; Fuessel S
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA.
    Oh TJ; Lim E; Bang BR; Lee JJ; Na YG; Shin JH; Lim JS; Song KH; An S
    BMC Cancer; 2022 Nov; 22(1):1195. PubMed ID: 36403035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls.
    Kim WT; Yun SJ; Yan C; Jeong P; Kim YH; Lee IS; Kang HW; Park S; Moon SK; Choi YH; Choi YD; Kim IY; Kim J; Kim WJ
    Yonsei Med J; 2016 Jul; 57(4):865-71. PubMed ID: 27189278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
    Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
    Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.
    Kodama H; Yoneyama T; Tanaka T; Noro D; Tobisawa Y; Yamamoto H; Suto S; Hatakeyama S; Mori K; Yoneyama T; Hashimoto Y; Kakizaki I; Nakaji S; Ohyama C
    Cancer Med; 2021 Feb; 10(4):1297-1313. PubMed ID: 33455069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease.
    Tripathi P; Somashekar BS; Ponnusamy M; Gursky A; Dailey S; Kunju P; Lee CT; Chinnaiyan AM; Rajendiran TM; Ramamoorthy A
    J Proteome Res; 2013 Jul; 12(7):3519-28. PubMed ID: 23731241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort.
    Goodison S; Ogawa O; Matsui Y; Kobayashi T; Miyake M; Ohnishi S; Fujimoto K; Dai Y; Shimizu Y; Tsukikawa K; Furuya H; Rosser CJ
    J Transl Med; 2016 Oct; 14(1):287. PubMed ID: 27717367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics.
    Shao CH; Chen CL; Lin JY; Chen CJ; Fu SH; Chen YT; Chang YS; Yu JS; Tsui KH; Juo CG; Wu KP
    Oncotarget; 2017 Jun; 8(24):38802-38810. PubMed ID: 28415579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bladder cancer biomarker array to detect aberrant levels of proteins in urine.
    Gogalic S; Sauer U; Doppler S; Preininger C
    Analyst; 2015 Feb; 140(3):724-35. PubMed ID: 25427191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urinary MicroRNAs as Potential Biomarkers of Bladder Cancer].
    Juráček J; Staník M; Peltanová B; Adamcová S; Doležel J; Fedorko M; Radová L; Slabý O
    Klin Onkol; 2018; 31(Supplementum1):155-157. PubMed ID: 29808692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-8 as a urinary biomarker for the detection of bladder cancer.
    Urquidi V; Chang M; Dai Y; Kim J; Wolfson ED; Goodison S; Rosser CJ
    BMC Urol; 2012 May; 12():12. PubMed ID: 22559832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry.
    Issaq HJ; Nativ O; Waybright T; Luke B; Veenstra TD; Issaq EJ; Kravstov A; Mullerad M
    J Urol; 2008 Jun; 179(6):2422-6. PubMed ID: 18433783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies.
    Cai Q; Wu Y; Guo Z; Gong R; Tang Y; Yang K; Li X; Guo X; Niu Y; Zhao Y
    Oncotarget; 2015 Nov; 6(35):37500-10. PubMed ID: 26462026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary cell-free microRNA-106b as a novel biomarker for detection of bladder cancer.
    Zhou X; Zhang X; Yang Y; Li Z; Du L; Dong Z; Qu A; Jiang X; Li P; Wang C
    Med Oncol; 2014 Oct; 31(10):197. PubMed ID: 25168920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.